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Camelpox is endemic in most camel rearing regions of the world, causing significant economic 23 
losses. However, its epidemiology is not extensively investigated. We conducted a cross 24 
sectional seroprevalence study of camelpox in Amibara and Awash Fentale districts in Afar 25 
region of Ethiopia from November 2014 to May 2015. In addition, participatory epidemiology 26 
(PE) was conducted to identify seasonal occurrence of the disease in the study districts. Blood 27 
samples were collected from 384 dromedary camels from 31 herds distributed in five pastoral 28 
associations (PAs) in the two districts. Serum samples were separated from the blood samples 29 
and tested for the presence of viral antibodies using virus neutralization test. Seroprevalence data 30 
were analyzed using multilevel mixed effects logistic regression models accounting for the 4-31 
level hierarchical data structure (camels nested in herds-herds in PA, and PA in district). For the 32 
participatory data, Kendall’s coefficient of concordance was used to assess agreements between 33 
the informants in identifying seasonal occurrences of the top five camel diseases. Camelpox 34 
antibodies were detected in 19.3% of camels (n=384), 81% of herds (n=31), and in all five PAs 35 
from the two districts in the Gabi Rasu zone of Afar region, Ethiopia. The seroprevalence did not 36 
significantly vary between herds, PAs or districts suggesting the widespread occurrence of the 37 
disease. Estimated age stratified basic reproduction number (R0) was 1.25 (95% CI: 0.62 – 2.19). 38 
Camelpox was identified as one of the top five common camel diseases in the area. The 39 
widespread occurrence of the disease can be attributed mainly to the commingling of camels 40 
from many herds during seasonal migration in search of feed and water, a practice very common 41 
under pastoral production systems. Although the PE informants indicated the clinical disease to 42 
be more common in young animals, seropositivity was higher in older animals. Camelpox 43 
commonly occurs during the minor and major rainy seasons. In conclusion, camelpox is found to 44 
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be endemic in Afar pastoral region with sporadic outbreaks occurring during rainy seasons. 45 
Vaccination and improved camel management practices particularly during the high-risk period 46 
can be viable strategies to reduce the burden of the disease. 47 
 48 
Key words: Camelpox; Camel; Basic reproduction number; Participatory epidemiology; 49 
Seroprevalence; Virus neutralization test. 50 
 51 
Abbreviations: PE = participatory epidemiology; PA = pastoral association; SSI = semi 52 
structured interviews 53 
  54 
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1. Introduction  55 
Camelpox is a contagious infectious disease of dromedary camels (Camelus dromedarius) 56 
caused by camelpox virus that belongs to the genus Orthopoxvirus (Azwai et al., 1996). The 57 
disease occurs in all camel rearing countries except in Australia, causing severe economic losses 58 
(Fenner et al., 1989; Azwai et al., 1996). The considerable economic loss of the disease is 59 
through its high morbidity, a relatively high mortality in young animals, loss of condition in all 60 
ages, reduced milk production in lactating camels (Azwai et al., 1996), and abortion in pregnant 61 
camels (Al-Zi’abi et al., 2007; Mahmoud et al., 2012). In addition, the appearance of camelpox 62 
in herds favors secondary infections from other circulating diseases from which camels can die 63 
(Duraffour et al., 2011). The mortality rate in adult animals ranges between 5% and 28%, and in 64 
young animals between 25% and 100% (Mayer and Czerny, 1990). The presence of the disease 65 
in a country causes restriction in the trade of live camels and their products (Bhanuprakash et al., 66 
2010).   67 
Camelpox is also important because of its potential zoonotic transmission affecting 68 
humans (Azwai et al., 1996). Several cases have been reported in humans (Kriz, 1982) most 69 
recently in India (Bera et al., 2011) with clinical manifestations such as papules, vesicles, 70 
ulceration and finally scabs on fingers and hands. The World Organization for Animal Health 71 
(OIE) lists camelpox as a reportable disease (OIE, 2014a). Camelpox is also classified as risk 72 
group 2 pathogen for human infection, and recommended to be handled with appropriate 73 
measures (OIE, 2014b).  74 
 Camelpox virus is host-specific and dependent on a single host, which makes it a 75 
potential target for control and eradication. Unfortunately, effective control programs such as 76 
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quarantine measures and restriction of camel movement appear to be of limited success owing to 77 
the migratory pattern of camels and the difficulty of reaching the animals due to poor 78 
infrastructures under most camel rearing pastoral regions. Therefore, vaccination is a viable 79 
alternative to control the disease in endemic countries (Khalafalla and El-Dirdiri, 2003). 80 
Although vaccination is not widely applied, camelpox vaccine production is being reported from 81 
many countries including Saudi Arabia (Hafez et al., 1992), United Arab Emirates (Wernery and 82 
Zachariah, 1999), Morocco (El Harrak and Loutfi, 2000) and Mauritania (Nguyen et al., 1996). 83 
Recently, camelpox vaccine was developed in Ethiopia by the National Veterinary Institute, 84 
which is the first type of vaccine for dromedary camels in the country. 85 
To carry out an effective control or eradication programs of camelpox through strategic 86 
vaccination, a thorough understanding of the epidemiology of the disease in a specific 87 
geographic area has a paramount importance. Although the disease was confirmed to occur in 88 
Ethiopia (Ayelet et al., 2013) and recognized for its economic losses, to the best of our 89 
knowledge, no study has been reported on the seroepidemiology of the disease in the country. 90 
The objective of this study was to investigate the seroprevalence and determine the seasonal 91 
occurrence of camelpox in Afar region of Ethiopia. This study will enhance our knowledge in the 92 
epidemiology of camelpox in Ethiopia, and to improve camelpox mitigation strategies such as 93 
the timing of vaccination or other preventive measures to be taken. 94 
 95 
2. Materials and methods 96 
 97 
2.1. Description of the study area 98 
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The study was carried out from November 2014 to May 2015 using a cross sectional 99 
seroprevalence study (Thrusfield, 2005; Dohoo et al., 2009), and a participatory epidemiology 100 
(Catley et al., 2012). The study was conducted in Amibara and Awash Fentale districts of Gabi 101 
Rasu zone in Afar region of Ethiopia. Afar region is located in North Eastern part of Ethiopia, 102 
and is characterized by a pastoral life style. The region has a great potential of livestock 103 
resources comprising of 2.3 million cattle, 4.3 million goats, 2.5 million sheep, 0.8 million 104 
camels and 0.19 million equines that support the region and contributes to the national economy 105 
(CSA, 2010). The Afar region is administratively divided into five zones, 32 districts and 401 106 
pastoral associations (PAs; the lowest administrative unit in Ethiopia). Gabi Rasu (formerly 107 
known as Zone Three) is one of the administrative zones located in the southern part of the 108 
region (Fig. 1). Gabi Rasu zone is characterized by arid and semi-arid agro-climatic conditions 109 
with annual rainfall that ranges from 200 to 700 mm. According to the data obtained 110 
from the meteorological station of Werer Agricultural Research Center, the mean annual 111 
minimum and maximum temperatures are 19.1 and 34.3°C, respectively. Gabi Rasu zone was 112 
selected based on its convenience for access by ground transportation, and due its high camel 113 
production potential. The zone consists of six districts, predominantly occupied by pastoral and 114 
agro-pastoral communities. The two selected districts, Amibara and Awash Fentale, are situated 115 
in the dry lowlands of the rift valley, at about 230 and 280 km northeast, respectively from the 116 
capital Addis Ababa.  117 
 118 
2.2. Seroprevalence study 119 
 120 
2.2.1. Sampling design 121 
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A stratified, 3-stage sampling design in which samples were stratified by two study districts from 122 
the Gabi Rasu zone was employed. Of five zones in the Afar region, Gabi Rasu zone was 123 
purposively selected based on their camel production potential and accessibility to road 124 
transportation. Of six districts in Gabi Rasu zone, Amibara and Awash Fentale districts were 125 
further selected due to higher reports of camel health problems by the zone in both districts. Five 126 
PAs (three from Amibara district and two from Awash Fentale district) were randomly selected 127 
by a lottery system from the list of PAs obtained from the Districts’ Pastoral Agriculture and 128 
Rural Development Offices. A total of 31 herds (15 from Amibara and 16 from Awash Fentale 129 
districts) were selected by systematic random sampling in which the first herd was randomly 130 
selected by a lottery system, and then every other herd was sampled until the desired sample size 131 
was achieved. If herd owners did not consent, the next herd was sampled. Within the selected 132 
herds, camels were selected by simple random sampling method. Camels over six months of age 133 
were sampled from each herd to avoid nonspecific serologic reactions due to circulating maternal 134 
antibodies (Nothelfer et al., 1995; Mahmoud et al., 2012). 135 
The total number of camels for this study was calculated using a formula for the 136 
estimation of proportion (Dohoo et al., 2009) by considering 95% confidence level, 5% precision 137 
and 50% seroprevalence, due to lack of previous seroprevalence report in the country. This 138 
resulted in a total of 384 camels to be sampled for the determination of antibody prevalence 139 
against camelpox. However, since random sampling of camels was not cost effective nor 140 
practically feasible, we tried to distribute the number of camels sampled over many herds, and 141 
PAs to potentially increase the variability and precision of the seroprevalence estimate. The 142 
study animals included camels of different age and of both sexes reared under extensive 143 




2.2.2. Serum sample collection and antibody detection  146 
After animals were physically restrained, blood was collected from jugular vein in to plain 147 
vacutainer tubes. The blood tubes were left to stand overnight at room temperature, after which 148 
the blood was centrifuged at 3000 rpm for 15 min to separate the serum. Separated serum 149 
samples were transferred to a new tube and stored at 4°C until submitted to virology laboratory 150 
where they were stored at -20°C until processed for the detection of camelpox antibodies.  151 
Serum samples were analyzed by virus neutralization test to detect the presence of serum 152 
specific antibodies against camelpox virus by in vitro neutralization of the viral cytopathic effect 153 
on cell culture. The test was conducted at the National Animal Health Diagnostic and 154 
Investigation Center (Sebeta, Oromia, Ethiopia) following procedures recommended by the 155 
World Organization for Animal Health (OIE, 2014b). The test method was based on a reaction 156 
between the virus and specific antibody in the test serum. Virus and products containing a 157 
neutralizing antibody were mixed under appropriate conditions and then inoculated into cell 158 
culture. The presence of un-neutralized virus was detected by plaque formation (cytopathic 159 
effect) on the cell culture. A loss of infectivity is caused by interference by the bound antibody 160 
with any of the steps leading to the release of the viral genome from the host cells including 161 
attachment, infection, or viral release. 162 
 163 
2.3. Participatory epidemiology 164 
Initially questionnaire survey using semi structured interviews (SSI) was conducted on 30 165 
respondents from both districts to get a baseline information about the common camel diseases in 166 
the area. At this phase the respondents listed major camel diseases by their local names with their 167 
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clinical symptoms and ranked them based on their frequency of occurrences using open-ended 168 
questions. The top 5 ranked diseases were then selected for subsequent participatory 169 
epidemiologic studies. The participatory epidemiology was performed using 12 independent 170 
informant groups where each group was composed of 5 - 10 participants. Six groups were 171 
interviewed from each district, and the participants included camel owners whose camels were 172 
being sampled. Other pastoralists present nearby with good camel herding experiences, and rich 173 
indigenous knowledge related to camel diseases and health care were also invited to join the 174 
discussion. Seasonal calendars and SSI were used to identify the seasonal occurrences of the five 175 
camel diseases identified through simple ranking method (FAO, 2000; Catley et al., 2012). All 176 
PAs selected for serum sample collection were included in this study. The method was pre-tested 177 
on animal health workers and camel owners before it was used for the actual field work to ensure 178 
that the method was understood and the questions were clear. The survey team was composed of 179 
three interviewers: a team leader (researcher), a community mobiliser and a translator. The 180 
community mobiliser made prior arrangements and preparations with the pastoralists in each PA 181 
and ensured time and place for the interview. The local language of the region “Afar” was used 182 
during the interview in both phases.  183 
 184 
2.3.1. Seasonal calendar  185 
Seasonal calendars- a time-related data source- were used to describe the seasonal occurrences of 186 
the five most common camel diseases selected using simple ranking method (Ameri et al., 2009). 187 
To construct a seasonal calendar, the four Afar seasons in their local names were represented by 188 
objects: a stick with green leaves for ‘Kerma’ (the major rainy season between July and August), 189 
green stick without leaf for ‘Gilal’ (the dry and cold season between September and February), 190 
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stick with few green leaves for ‘Sugum’ (the short rainy season between March and April) and a 191 
dry stick without leaves for ‘Hagay’ (the hot and dry season between May and June) on the X-192 
axis. Pieces of papers with pictures and local names of the diseases printed on them were placed 193 
along the Y-axis. These were then placed on the flip chart and explained to the participants after 194 
they were sited in convenient places. The participants were then requested to explain the 195 
meaning of each symbol to make sure they understood the symbols. The participants were then 196 
given 30 stones and asked to show the relative occurrence of each disease in each season. The 197 
seasons, diseases and the number of stones were kept constant across all the participant groups to 198 
ensure the reproducibility of the technique.  199 
 200 
2.3.2. Semi-structured interviews  201 
Following scoring of the seasonal calendars, the results were discussed with the participants 202 
using open and probing questions through SSIs. The informant groups were specifically probed 203 
more on the disease of interest (camelpox) regarding its seasonal occurrence, impact, age group 204 
affected and predisposing factors.  205 
2.4. Data analysis 206 
2.4.1. Analysis of seroprevalence data 207 
Field and laboratory data were entered in to Excel worksheets (Microsoft Corp., Redmond, WA, 208 
USA) double checked, and further verified by a second person. Data were analyzed using 209 
Stata/SE 15.1 (Stata Corp. LLC, 2017). For descriptive statistics the proportion of sex, number of 210 
herds, and number of camels sampled in each district were calculated and compared by two-211 
sample test for proportions. Median and range were used to describe the frequency distributions 212 
of age and herd size, and a two-sample Wilcoxon rank-sum (Mann-Whitney) test was used to 213 
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compare the median values between the two study districts. Proportion of animals sampled per 214 
herd was calculated as the number of camels sampled divided by the herd size.  215 
Multilevel mixed effects logistic regression was conducted to account for a 4-hierarchical 216 
data structure in which camels are nested in herds, herds nested in PAs, and PAs nested in 217 
districts. Herd and PA were modeled as random effects, while the highest level, district, was 218 
modeled as a fixed effect variable. In addition, the model consisted of the fixed effects of herd 219 
size (continuous variable) and age (as a categorical variable), and sex (as a categorical variable). 220 
Age was grouped into four categories: 0-5 years, 6-10 years, 11-15 years, and >15 years old. We 221 
first built a full model with all variables included. Then variables were excluded step by step by 222 
removing the non-significant terms starting with variables with the highest P-value. The full and 223 
the reduced models were compared by maximum likelihood ratio test for significance. Marginal 224 
mean prevalence was obtained from the final model. Maximum Likelihood Estimator method 225 
was used to calculate the basic reproduction number (R0) from age stratified seroprevalence data 226 
(Ferguson et al., 1999; Boelle and Obadia, 2015).  227 
 228 
2.4.2. Analysis of participatory epidemiological data  229 
Data collected by seasonal calendar were summarized using median scores and their minimum 230 
and maximum scores. The Kendall’s coefficient of concordance (W) was used to quantify 231 
agreements between the informant groups. Kendall’s W values were categorized as weak (< 232 
0.26; P > 0.05), moderate (0.26 - 0.38; P < 0.05), and good (>0.38; P < 0.01 to <0.001). 233 
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Kendall’s W was calculated by assuming the rankings of four objects (seasons) by 12 judges 234 
(groups of informants) (Seigel and Castellan, 1994).  235 
3. Results 236 
3.1. Description of the study animals 237 
Thirty-one herds (15 from Amibara, and 16 from Awash Fentale) were selected from the two 238 
study districts. The number of camels sampled per herd ranged from 10% to 100% (Table 1). 239 
Herd size and the number of camels studied did not significantly (P > 0.05) differ between the 240 
two districts (Table 2). Female camels represented 87% of the total camels studied (n=384). 241 
There was significant (likelihood-ratio χ2 P = 0.002) difference in the sex distribution between 242 
the two districts: the proportion of females was higher in the Amibara district while the 243 
proportion of males was higher in the Awash Fentale district (Table 2). Similarly, the age 244 
distribution of the study camels was significantly (LR χ2 P < 0.001) different between the 245 
districts: while higher proportions of older camels were sampled in Amibara, relatively younger 246 
camels were sampled from Awash Fentale district (Table 2).  247 
 248 
3.2. Seroprevalence of camelpox 249 
Across the two districts of the Gabi Rasu zone of Afar region, the overall seroprevalence of 250 
camelpox was 19.3% (95% CI: 15.4 - 23.1%). When stratified by district the seroprevalence was 251 
20% (95% CI: 14.7 – 25.3%) in Amibara, and 18.3% (95% CI: 12.5 – 24.2%) in Awash Fentale 252 
district. Seropositive camels were detected in 81% of the herds (n=31). No seropositive camel 253 
was detected in two herds from Amibara, and three herds in Awash Fentale. Among the positive 254 
herds, herd level prevalence varied from 7% (in Awash Fentale) to 50% (in Amibara) as shown 255 
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in Fig. 2. All the six PAs had at least one herd with seropositive camel. However, all the levels of 256 
potential clustering effects (herd, PA, and district) were not significantly associated with 257 
seroprevalence (Table 3). Only the age of the animal was found to be significantly associated 258 
with seropositivity after adjusting for the various levels of clustering variables both in the full 259 
model (Table 3), and the final model (Table 4). Older camels (>10 years of age) are three times 260 
more likely to be seropositive when compared to the younger age group, 0 – 5 years old (Table 261 
4). The seroprevalence shows an increase with age (Fig. 3). The age stratified basic reproduction 262 
number (R0) estimate for the camelpox infection using Maximum Likelihood method was 1.25 263 
and the 95% CI range was between 0.62 – 2.19. The point estimate indicates that the disease will 264 
spread out in the population (will not die out in the long term), but the estimate was not 265 
statistically significant. 266 
 267 
3.3. Questionnaire and participatory epidemiological surveys  268 
During the initial questionnaire survey, various camel diseases with their symptoms were 269 
identified by the pastoralists based on their common occurrences. Subsequently top five diseases 270 
including camelpox (Fig. 4) were selected by simple ranking method (Ameri et al., 2009) for the 271 
seasonal calendar study. In addition, the occurrence of tick infestation was included because of 272 
its possible association with the occurrence of the targeted diseases. Results of the 12 seasonal 273 
calendars are presented in Fig. 4. Good agreement was observed among the 12 informant groups 274 
concerning seasonal patterns of the selected camel diseases except for galideli (abscess) which 275 
scores weak agreement (W= 0.171). Camelpox (galiguduf/ambraruk) incidence peaks during 276 
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minor (Sugum) and major (Kerma) rainy seasons with median scores of 16 (95% CI: 8-28) and 277 
13.5 (95% CI: 2-22) respectively (Fig. 4).  278 
 279 
4. Discussion  280 
4.1. Seroprevalence  281 
The epidemiology of most camel diseases including camelpox is not extensively investigated. 282 
Most of the studies on camelpox were mainly focused on the isolation and characterization of the 283 
causative virus (Renner-Müller et al., 1995; Pfeffer et al., 1998; Salem et al., 2008; Yousif and 284 
Al-Naeem, 2012; Ayelet et al., 2013). In this seroepidemiologic investigation, out of 384 camels, 285 
31 herds and five PAs sampled from two districts of Gabi Rasu zone in Afar region, camelpox 286 
antibodies were detected in 74 (19.3%) camels, 25 herds (81%) and all PAs. These findings show 287 
that there is a high seroprevalence of camelpox in the herds investigated regardless of their 288 
geographic location. Serological evidence of the present study together with the confirmatory 289 
report of the disease (Ayelet et al, 2013) from Afar region suggest that the disease is endemic in 290 
the area. According to the information collected from the animal health sector of the Pastoral 291 
Agriculture and Rural Development Office of the districts and camel owners, the camel 292 
population in the study area has never been vaccinated against any diseases including camelpox. 293 
Therefore, our findings indicate a seropositivity in response to natural infection, and we 294 
speculate that camelpox infection is active in the area. However, confirmation of this claim 295 
requires isolation of the virus from clinical cases or detection of the viral antigen as proxy (OIE, 296 
2014b). Unfortunately, however, we did not encounter any active cases of camelpox in this 297 
cross-sectional study population or in a cohort of camels, from 15 of the herds included in this 298 
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report that were followed. A previous study (Ayelet et al., 2013) that looked for the occurrence 299 
of clinical cases of camelpox in another district in Afar region, and four other districts in Somali 300 
region isolated the virus and further characterized by PCR. 301 
The antibody prevalence reported here is relatively higher than other seroepidemiologic 302 
studies of camelpox that reported the presence of neutralizing antibodies from similarly 303 
unvaccinated camels: 9.8% in Libya (Azwai et al., 1996) and 9.14% in Saudi Arabia (Housawi, 304 
2007). On the other hand, higher prevalence values of neutralizing antibodies have been reported 305 
from similarly unvaccinated camel populations but following disease outbreaks in 72.5% of 306 
camels in Sudan (Khalafalla et al., 1998) and in 100% of clinical cases and in-contact apparently 307 
healthy camels in Egypt (Mahmoud et al., 2012). Camelpox prevalence based on clinical cases, 308 
ranging from 3% to 14.2%, has been reported from various parts of Ethiopia (Tefera and 309 
Gebreab, 2001; Megersa, 2010; Ayelet et al, 2013). It was expected to find higher serological 310 
prevalence than clinical prevalence as poxvirus antibodies can be detected in animal sera much 311 
more frequently than poxviruses can be isolated from them (Marennikova et al., 1975).  312 
Among the risk factors screened for an association with seropositivity of camelpox 313 
antibody, age group was found to be the only significantly associated factor, where 314 
seroprevalence increased positively with age. This can be explained by the fact that adult animals 315 
are consistently exposed resulting in a cumulative increase in neutralizing antibody titer than the 316 
younger age group. In addition, camelpox is commonly fatal in young camels (Kriz, 1982; 317 
Khalafalla and Mohamed, 1996; Mahmoud et al., 2012), where antibody detection is less likely. 318 
Khalafalla and Mohamed (1996) reported increasing clinical cases of camelpox in younger 319 
(under 1 year of age) camels than in the adult age group. Generally, young animals under 4 years 320 
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of age in a herd experience a more severe and generalized form of the disease resulting in high 321 
mortality occasionally due to waning of acquired maternal immunity after 5–8 months (Nothelfer 322 
et al., 1995; Mahmoud et al., 2012). Low basic reproduction number either indicates the disease 323 
occurs at endemic level, or the age record obtained from the owners was not accurate resulting in 324 
the underestimation of the parameter. Further studies may be needed to supplement the estimated 325 
parameter.   326 
We did not observe any statistically significant difference in the seroprevalence between 327 
males and females. There are contradictory reports in the literature (Kriz, 1982; Khalafalla and 328 
Mohamed, 1996; Mahmoud et al., 2012) with regards to the role of the sex of camel for 329 
susceptibility to camelpox. However, we note that sex was disproportionately distributed in the 330 
current study in which over 87% of the camels tested were females. Typically, under the pastoral 331 
production systems female camels are kept for breeding stock and milk production whereas 332 
males are sold for meat. Seropositivity was not significantly affected by herd size as well as by 333 
study districts. These findings can be attributed to the contagious nature of camelpox virus which 334 
spreads between animals within the same herd or between herds when camels congregate during 335 
grazing and watering. In addition, the pastoral production system itself which is characterized by 336 
migratory nature of camel herders coupled with sharing communal grazing and watering points, 337 
as well as the close proximity of the two districts (Fig. 1) also contribute for the observed lack of 338 
statistically significant variations among the herds, PAs and the districts. Under pastoral 339 
production system it is difficult to consider herds as independent units, rather they comprise part 340 
of a larger animal production ecology. Furthermore, selection bias (Dohoo, 2014) might have 341 
been introduced at each sampling stages: districts-herds-animals as strict random sampling of 342 
these units was not possible for logistical and practical reasons during this study. Nevertheless, 343 
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our findings suggest the widespread occurrence of camelpox in the Afar pastoral production 344 
system, and that it is not limited to specific herds, PAs or districts.  345 
4.2. Participatory epidemiology 346 
Our participatory epidemiologic investigation identified the seasonal occurrence of camelpox 347 
during the short and long rainy seasons. As explained by the informant groups, the high 348 
incidence of camelpox during the rainy seasons is associated with the return of camels from 349 
grazing places during the migration season in the previous dry season, and congregation of the 350 
animals in small areas that favors the transmission of the disease. High humidity (hot 351 
temperature and rain) during the minor rain season (Sugum) was also pointed as another 352 
predisposing factor for the higher occurrence of the disease during this season. As indicated by 353 
the informants, the disease clinically affects mainly young camels that are just allowed to graze 354 
during the rainy seasons. Increased frequency of contacts with other camels, and grazing on 355 
thorny plant species and bushes which are abundant during rainy seasons were also mentioned as 356 
predisposing factors for the disease in young camels. Our participatory epidemiology based 357 
finding generally agrees with previous reports that demonstrated the frequent outbreaks with a 358 
more severe form of the disease during rainy seasons (Wernery et al., 1997a, 1997b; Wernery 359 
and Kaaden, 2002; Khalafalla and Ali, 2007; OIE, 2014b). Consistent with our finding, a 360 
relatively higher incidence of camelpox during Sugum (short rainy season) compared to Kerma 361 
(major rainy season) has been reported (Megersa, 2010). The author suggested that moisture 362 
enhances the mechanism of virus stability in the environment and increases subsequent 363 
transmission to susceptible animals during the rainy seasons.  364 
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The occurrences of the other camel diseases including respiratory diseases, mange mites, 365 
trypanosomosis, and ticks were associated with the long dry season, Gilal (September-February), 366 
and short dry season, Hagay (May-June), as opposed to that of camelpox (Fig. 4). This can be 367 
mainly attributed to feed shortage and subsequent starvation during dry seasons which 368 
predispose animals to various infections. Contrary to the present finding of higher density of the 369 
tick population during the long and short dry seasons (Fig. 4), the occurrence of camelpox with 370 
the increased density of the tick population during the rainy season has been reported (Wernery 371 
et al., 1997a). This requires further study on the diversity of biological rhythms, diapauses, 372 
biological clocks, daily and seasonal cycles utilized by arthropods (ticks and flies) for 373 
adaptations under Afar arid and semi-arid environmental conditions. Further studies are also 374 
recommended to ensure the involvement of arthropods in the transmission of camelpox virus 375 
(Duraffour et al., 2011).  376 
Pastoralists have a clear knowledge of the seasonality of camelpox which agrees with 377 
clinical and modern laboratory based scientific reports (Wernery et al., 1997a; Khalafalla and 378 
Ali, 2007; Megersa, 2010). However, some camel diseases such as trypanosomosis were reported 379 
to occur during the dry seasons by the informant groups, although it was known to occur 380 
commonly during the wet season when the biting fly population is abundant (Luckins, 1988). Its 381 
increased occurrence during the dry season as suggested by the informant groups can be 382 
associated with feed and water shortages that can result in reduced immune status of camels, 383 
with subsequent susceptibility to infections. The situation in camelpox was however different 384 
which was reported to occur mainly during the rainy season that shows synergic finding with the 385 
scientific reports based on standard epidemiologic investigations. Participatory epidemiology 386 
played a significant role in identifying the seasonal occurrence of camelpox, and other important 387 
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diseases of camels in the pastoral area which otherwise would have been very difficult using 388 
conventional epidemiologic studies.  389 
 390 
5. Conclusion  391 
Our results indicate the widespread occurrence of camelpox in Gabi Rasu zone of Afar region. In 392 
addition, camelpox was identified as one of the top five common camel diseases with its seasonal 393 
occurrence during rainy seasons. Targeted vaccination strategies before the start of the rainy 394 
seasons in combination with improved camel husbandry management practices can improve herd 395 
immunity thus reducing the disease burden. Since camels are the only reservoir host of camelpox 396 
virus, camelpox can be targeted for eradication through national and international strategic 397 
vaccinations and surveillance systems. The eradication effort requires the development of 398 
effective heat stable camelpox vaccine for use in hot, dry and inaccessible camel rearing regions 399 
of the world, and community involvement in the vaccination programs.  400 
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Figure legends 524 
Fig. 1. Geographical location of Gabi Rasu zone and the study districts for seroepidemiological 525 
and participatory epidemiology of camelpox in Afar region of Ethiopia.  526 
 527 
Fig. 2. Seroprevalence of camelpox in camel herds in Afar region of Ethiopia. 528 
 529 
Fig. 3. Model adjusted marginal seroprevalence of camelpox by age categories, and stratified by 530 
the study districts. 531 
 532 
Fig. 4. Seasonal calendar for the seasonal occurrences of the most common camel diseases in 533 
Gabi Rasu zone, Afar region of Ethiopia. Number of informant groups = 12; W= Kendall’s 534 
Coefficient of Concordance (ns P > 0.05 [non-significant]; **P < 0.01; ***P < 0.001). W values 535 
vary from 0 to 1.0; the higher the value, the higher the level of agreement between the informant 536 
groups. The black dots represent the median scores (number of stones) that were used during 537 
construction of the seasonal calendars; minimum and maximum limits are shown in parentheses. 538 




Table 1 Number of camels sampled from each herd for seroprevalence study of camelpox in Afar, Ethiopia 541 
Amibara Awash Fentale 
PA* Herd id Herd size # sampled % sampled  PA* Herd id Herd size # sampled % sampled 
Halidegi 1 45 34 80  Deho 16 60 18 30 
2 20 14 70  17 40 17 40 
3 25 6 20  18 35 15 40 
4 120 26 20  19 60 15 30 
5 80 21 30  20 30 15 50 
6 55 24 40  21 20 10 50 
Bedhamo 7 60 20 30  22 15 3 20 
8 45 3 10  23 17 7 40 
Uduleisi 9 4 3 80  Sabure 24 200 20 10 
10 11 11 100  25 50 10 20 
11 7 7 100  26 65 15 20 
12 20 16 80  27 60 6 10 
13 7 4 60  28 30 6 20 
14 11 7 60  29 25 7 30 
15 9 8 90  Deho 30 40 6 20 
      31 55 10 20 
PA= pastoral association 542 
29 
 
Table 2 Description of the study animals for the seroprevalence study of camelpox in two 543 






Amibara Awash Fentale P-value 
Number of herds   15 16 31 0.8587 
Herd size (median, range)  45 (4-120) 50 (15-200) 45 (4-200) 0.05 
Number of camels examined 204 180 384 0.2216 
% Female 92.2 81.7 87.2 0.002 






Table 3 Full model multilevel mixed effects logistic regression for the analysis of seroprevalence of camelpox in Afar region of 548 
Ethiopia 549 
Variables# Coefficients Standard error P-value 95% confidence interval 
Herd size (number of animals)  0.004 0.0029 0.169 -0.002 0.01 
Age*                   6-10 years 0.15 0.3695 0.694 -0.58 0.87 
                           11-15 years 0.93 0.3511 0.008 0.24 1.62 
                            >15 years 0.96 0.4578 0.036 0.06 1.86 
Sex=male -0.372 0.515 0.470 -1.38 0.64 
District=Awash Fentale -0.132 0.278 0.635 -0.68 0.41 
Intercept -1.85 0.3137 - -2.47 -1.24 
#only the fixed effects part of the model is presented. The random effects, pastoral association, and herd had a variance of 0.00 550 
indicating they are not significant. 551 




Table 4 Final multilevel mixed effects logistic regression model for the association between age 554 
of camels and camelpox seropositivity in Afar region of Ethiopia.  555 
Variable Odds Ratio Standard error P-value 95% confidence interval  
Age*                  6-10 years 1.3 0.4528 0.509 0.63 2.6 
                           11-15 years 2.7 0.8996 0.003 1.4 5.2 
                           >15 years 2.9 1.3072 0.016 1.2 7.0 
District=Awash Fentale 0.85 0.2331 0.545 0.5 1.5 
*0-5 years old is a referent age category. Results are adjusted for clustering effects of herds, 556 





















































(W = 0.17 ns) 
 
● ● ● ● 
 ● ● ● ● 
 ● ● ● 
10.5 (2-19) 
● ● ●  
● ● ● ●  












(W = 0.67***) 
 
● ● ● ● ●  
● ● ● ● ●  








● ● ● ● ●  
● ● ● ● ● ●  














● ● ● ● ● ● ● ●  
● ● ● ● ● ● ● ● ● 




















● ● ● ● ● ● ● ● ● ● 
● ● ● ● ● ● ● ● ● ● 





























● ● ● ● ● ● ● ● 
 ● ● ● ● ● ● ● ● 












● ● ● ● 
● ● ● ● ●  








● ● ● ● ● 
● ● ● ● ● 
● ● ● ● ● 
 
15 (6-23) 
 
